Get Started Today

Please fill out the form below and a member of our
team will be in touch with you soon.

    hero image

    Coronavirus and the impact on making R&D tax credit claims

    Following a recent HMRC update, Jon Connor, R&D tax specialist at PM+M, answers questions which are raising concern for many businesses in relation to making R&D claims.


    Will there be delays in HMRC’s processing of an R&D claim?

    As a result of the recent downturn in the markets and the ongoing coronavirus pandemic, some businesses are already feeling a significant financial impact. For many, their greatest concern is around cash flow management. Making a R&D claim now could help with short-term cash flow potentially benefiting businesses throughout the pandemic.

    We are seeing several businesses bring forward their R&D claim submissions. HMRC has said that although they are seeing pressure on their operational resources, their priority is to maintain their aim of clearing 95% of SME tax credit claims within 28 days. They have implemented contingency plans to support this, including applying extra resource and are currently meeting this aim.


    If we intend to use the Coronavirus Business Interruption Loan Scheme (CBILS) will this have an impact on our SME R&D claim?

    The CBILS has been notified as a state aid under the European Commission’s new temporary framework for COVID-19. As this is a notified state aid, companies who would otherwise make SME R&D claims could instead potentially be forced to claim the less generous Research and Development Expenditure Credit (generally used for larger companies).

    The critical factor will be whether the CBILS relates specifically to the company’s R&D project or R&D expenditure, or whether it will be intended to be used more generally to support the business. If the latter, we would expect that R&D tax credits should still be available. Outlining the purpose of the loan will be key to maximising the potential relief over the next 18 months. HMRC have said they will be monitoring the application of this rule and welcome feedback.


    If we have other liabilities owing to HMRC, will R&D claims be paid out in full?

    For those who make SME R&D claims, HMRC are considering this and the hope is that they will prioritise payment of R&D credits over collection of other liabilities in the current environment. For RDEC claims the offset is required.


    Can the ‘going concern’ requirement in the SME scheme be set aside?

    It is a statutory requirement that companies making R&D tax credit claims can certify that their business is a going concern, hence HMRC cannot ignore it. HMRC’s latest update on this indicates that they will look to the last published accounts. In many cases, these will have been prepared before the effects of COVID-19 and there should therefore be no impact on the going concern requirement.

    The suggestion here is that such companies would be able to submit claims now even if they would have some doubts about their current going concern status due to any uncertainty surrounding coronavirus.

    For companies currently finalising accounts, the position is less clear. HMRC are monitoring the impact of the pandemic on their customers’ ability to meet the going concern requirement and they suggest that if you fall into this category you should approach them if it is causing genuine operational difficulty.


    For further advice, please get in touch with Jon using the button below.


    This information is correct as of 8 April 2020. This blog is for general guidance only. Recipients should not act upon any of the information provided without seeking specific professional advice tailored to your circumstances, requirements or needs. Please contact PM+M before making any decisions based on any matters relating to this blog.

    Stay Connected